EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kramer, J. H.
Right arrow Articles by Weglicki, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kramer, J. H.
Right arrow Articles by Weglicki, W. B.
Experimental Biology and Medicine 228:665-673 (2003)
© 2003 Society for Experimental Biology and Medicine


ORIGINAL RESEARCH ARTICLE

Dietary Magnesium Intake Influences Circulating Pro-Inflammatory Neuropeptide Levels and Loss of Myocardial Tolerance to Postischemic Stress

Jay H. Kramer*,1, I. Tong Mak*, Terry M. Phillips{ddagger},2 and William B. Weglicki*,{dagger}

* Departments of Physiology and Experimental Medicine and
{dagger} Medicine, and
{ddagger} Immunochemistry Laboratory, George Washington University Medical Center, Washington, DC 20037

Severe dietary Mg restriction (Mg9, 9% of recommended daily allowance [RDA], plasma Mg = 0.25 mM) induces a pro-inflammatory neurogenic response in rats (substance P [SP]), and the associated increases in oxidative stress in vivo and cardiac susceptibility to ischemia/reperfusion (I/R) injury were previously shown to be attenuated by SP receptor blockade and antioxidant treatment. The present study assessed if less severe dietary Mg restriction modulates the extent of both the neurogenic/oxidative responses in vivo and I/R injury in vitro. Male Sprague-Dawley rats maintained on Mg40 (40% RDA, plasma Mg = 0.6 mM) or Mg100 (100% RDA, plasma Mg = 0.8 mM) diets were assessed for plasma SP levels (CHEM-ELISA) during the first 3 weeks and were compared with the Mg9 group; red blood cell (RBC) glutathione and plasma malondialdehyde levels were compared at 3 weeks in Mg9, Mg20 (plasma Mg = 0.4 mM), Mg40, and Mg100 rats; and 40-min global ischemia/30-min reperfusion hearts from 7-week-old Mg20, Mg40, and Mg100 rats were compared with respect to functional recovery (cardiac work, and diastolic, systolic, and developed pressures), tissue LDH release, and free radical production (ESR spectroscopy and {alpha}-phenyl-N-tert butylnitrone [PBN; 3 mM] spin trapping). The Mg40 diet induced smaller elevations in plasma SP (50% lower) compared with Mg9, but with a nearly identical time course. RBC glutathione and plasma malondialdehyde levels revealed a direct relationship between the severity of oxidative stress and hypomagnesemia. The dominant lipid free radical species detected in all I/R groups was the alkoxyl radical (PBN/alkoxyl: {alpha}H = 1.93 G, {alpha}N = 13.63 G); however, Mg40 and Mg20 hearts exhibited 2.7- and 3.9-fold higher alkoxyl levels, 40% and 65% greater LDH release, and lower functional recovery (Mg20 < Mg40) compared with Mg100. Our data suggest that varying dietary Mg intake directly influences the magnitude of the neurogenic/oxidative responses in vivo and the resultant myocardial tolerance to I/R stress.

Key Words: dietary magnesium • substance P • glutathione • malondialdehyde • postischemic heart recovery • postischemic free radicals




This article has been cited by other articles:


Home page
Arch. Dis. Child.Home page
M Rodriguez-Moran and F Guerrero-Romero
Serum magnesium and C-reactive protein levels
Arch. Dis. Child., August 1, 2008; 93(8): 676 - 680.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Sontia, A. C.I. Montezano, T. Paravicini, F. Tabet, and R. M. Touyz
Downregulation of Renal TRPM7 and Increased Inflammation and Fibrosis in Aldosterone-Infused Mice: Effects of Magnesium
Hypertension, April 1, 2008; 51(4): 915 - 921.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
Y. Song, T. Y Li, R. M van Dam, J. E Manson, and F. B Hu
Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women
Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1068 - 1074.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
J. H Kramer, I. T. Mak, B. F. Dickens, and W. B. Weglicki
Modulation of circulating substance P in Mg-deficient (MgD) rats by NMDA receptor and neutral endopeptidase inhibitors
FASEB J, April 1, 2007; 21(6): A1066 - A1066.



Home page
Am. J. Clin. Nutr.Home page
L. J Dominguez, M. Barbagallo, F. Lauretani, S. Bandinelli, A. Bos, A. M. Corsi, E. M Simonsick, and L. Ferrucci
Magnesium and muscle performance in older persons: the InCHIANTI study.
Am. J. Clinical Nutrition, August 1, 2006; 84(2): 419 - 426.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
K. B. Franz
A Functional Biological Marker is Needed for Diagnosing Magnesium Deficiency
J. Am. Coll. Nutr., December 1, 2004; 23(6): 738S - 741S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Experimental Biology and Medicine.